Respiratory News and Research RSS Feed - Respiratory News and Research

Rosuvastatin promotes bone growth in mice with achondroplasia symptoms

Rosuvastatin promotes bone growth in mice with achondroplasia symptoms

Skeletal dysplasia is a group of rare diseases that afflict skeletal growth through abnormalities in bone and cartilage. Its onset hits at the fetal stage and is caused by genetic mutations. [More]
Adding common epilepsy drug to morphine can result in better pain control, say IU researchers

Adding common epilepsy drug to morphine can result in better pain control, say IU researchers

Adding a common epilepsy drug to a morphine regimen can result in better pain control with fewer side effects. Moreover, the combination can reduce the dosage of the opioid needed to be effective, according to a team of pain researchers at Indiana University. [More]
Zebrafish may hold key to unlocking a leading cause of respiratory diseases

Zebrafish may hold key to unlocking a leading cause of respiratory diseases

A small freshwater fish found in many tropical aquariums may hold the key to unlocking one of the leading causes of respiratory diseases in humans. [More]
Lilly, AstraZeneca partner to co-develop and commercialize potential Alzheimer's disease treatment

Lilly, AstraZeneca partner to co-develop and commercialize potential Alzheimer's disease treatment

Eli Lilly and Company and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. [More]
NSF, NIH, USDA receive more than $12 million in new EEID grants

NSF, NIH, USDA receive more than $12 million in new EEID grants

Ebola, MERS (Middle East Respiratory Syndrome), malaria, antibiotic-resistant infections: Is our interaction with the environment somehow responsible for their increased incidence? [More]
AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules. [More]
Pollution in many cities threatens brain development in children

Pollution in many cities threatens brain development in children

Pollution in many cities threatens the brain development in children. Findings by University of Montana Professor Dr. Lilian Calder-n-Garcidue-as, MA, MD, Ph.D., and her team of researchers reveal that children living in megacities are at increased risk for brain inflammation and neurodegenerative changes, including Alzheimer's or Parkinson's disease. [More]
Now, women experiencing morning sickness can benefit from Diclegis drug

Now, women experiencing morning sickness can benefit from Diclegis drug

Up to 85 percent of pregnant women are affected by nausea and vomiting of pregnancy (NVP), more commonly known as morning sickness. [More]
Moms should be vaccinated for whooping cough during third trimester

Moms should be vaccinated for whooping cough during third trimester

Expectant moms should be vaccinated for pertussis, or whooping cough, during their third trimester, according to obstetricians at Loyola University Health System. Those in close contact with the infant also should be up to date with their whooping cough vaccine. [More]
Scientists identify how molecular motor essential for human development works

Scientists identify how molecular motor essential for human development works

Another mystery of the human body has been solved by scientists who have identified how a molecular motor essential for human development works. [More]
Researchers explain why people with asthma have hard time dealing with respiratory viruses

Researchers explain why people with asthma have hard time dealing with respiratory viruses

People with asthma often have a hard time dealing with respiratory viruses such as the flu or the common cold, and researchers have struggled to explain why. [More]
Novel virus could be source of severe respiratory disease in ball pythons

Novel virus could be source of severe respiratory disease in ball pythons

Researchers have identified a novel virus that could be the source of a severe, sometimes fatal respiratory disease that has been observed in captive ball pythons since the 1990s. The work is published this week in mBio-, the online open-access journal of the American Society for Microbiology. [More]

Patients with COPD would like healthcare professionals to discuss palliative care needs in more detail

Patients with COPD would like healthcare professionals to discuss palliative care needs in more detail, according to a new study. [More]
Study reveals how stem cells work to improve lung function in ARDS

Study reveals how stem cells work to improve lung function in ARDS

A new study has revealed how stem cells work to improve lung function in acute respiratory distress syndrome (ARDS). [More]
Birth weight measurements can be used to predict lung function during late teenage years

Birth weight measurements can be used to predict lung function during late teenage years

A new study has found that factors, such as birth weight, gestational age at birth and lung function, growth and other measures at 8 years, can be used to predict lung function during mid to late teenage years. [More]
New potential therapeutic targets for treatment of pulmonary arterial hypertension

New potential therapeutic targets for treatment of pulmonary arterial hypertension

Two new potential therapeutic targets for the treatment of pulmonary arterial hypertension, a deadly disease marked by high blood pressure in the lungs, have been identified by researchers at the University of Illinois at Chicago. [More]

Researchers suggest that proportion of IPF may be due to unknown exposure to asbestos

A proportion of idiopathic pulmonary fibrosis cases may be linked with asbestos exposure, according to the results of a new study. [More]
Researchers successfully evaluate new antibody-based drug for patients with severe asthma

Researchers successfully evaluate new antibody-based drug for patients with severe asthma

A team of researchers at McMaster University and St. Joseph's Healthcare Hamilton have successfully evaluated a new, antibody-based drug for certain patients with severe asthma. [More]
Ornamental birds and exposure to pigeons may contribute to hypersensitive pneumonitis

Ornamental birds and exposure to pigeons may contribute to hypersensitive pneumonitis

Ornamental birds and feather pillows, plus daily exposure to pigeons may contribute to the development hypersensitive pneumonitis, a disease that can cause irreversible damage to the lungs. [More]
New data from Boehringer's Phase III trial program evaluates efficacy of tiotropium in asthma patients

New data from Boehringer's Phase III trial program evaluates efficacy of tiotropium in asthma patients

Boehringer Ingelheim today presented new data from the company's Phase III trial program (UniTinA-asthma®) evaluating tiotropium in asthma, including the first study assessing the efficacy and safety of tiotropium in adolescent patients with symptomatic asthma. [More]